Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
CNS Neurosci Ther ; 17(1): 66-79, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20370806

RESUMO

The aim of the present study was to determine whether acetazolamide (AZ) contributes to the inhibition of the fast inactivating transient K(+) current (I(A) ) in adult rat nodose ganglion (NG) neurons. We have previously shown that pretreatment with either AZ or 4-AP attenuated or blocked the CO(2) -induced inhibition of slowly adapting pulmonary stretch receptors in in vivo experiments. The patch-clamp experiments were performed by using the isolated NG neurons. In addition to this, the RT-PCR of mRNA and the expression of voltage-gated K(+) (Kv) 1.4, Kv 4.1, Kv 4.2, and Kv 4.3 channel proteins from nodose ganglia were examined. We used NG neurons sensitive to the 1 mM AZ application. The application of 1 mM AZ inhibited the I(A) by approximately 27% and the additional application of 4-AP (1 mM) further inhibited I(A) by 48%. The application of 0.1 µM α-dendrotoxin (α-DTX), a slow inactivating transient K(+) current (I(D) ) blocker, inhibited the baseline I(A) by approximately 27%, and the additional application of 1 mM AZ further decreased the I(A) by 51%. In current clamp experiments, AZ application (1 mM) increased the number of action potentials due to the decreased duration of the depolarizing phase of action potentials and/or due to a reduction in the resting membrane potential. Four voltage-gated K(+) channel proteins were present, and most (80-90%) of the four Kv channels immunoreactive neurons showed the co-expression of carbonic anhydrase-II (CA-II) immunoreactivity. These results indicate that the application of AZ causes the reduction in I(A) via the inhibition of four voltage-gated K(+) channel (Kv) proteins without affecting I(D).


Assuntos
Acetazolamida/farmacologia , Potenciais de Ação/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Gânglio Nodoso/efeitos dos fármacos , Bloqueadores dos Canais de Potássio/farmacologia , Canais de Potássio de Abertura Dependente da Tensão da Membrana/efeitos dos fármacos , 4-Aminopiridina/farmacologia , Animais , Inibidores da Anidrase Carbônica/farmacologia , Células Cultivadas , Interações Medicamentosas , Masculino , Neurônios/classificação , Gânglio Nodoso/citologia , Técnicas de Patch-Clamp , Canais de Potássio de Abertura Dependente da Tensão da Membrana/fisiologia , Subunidades Proteicas , Ratos , Ratos Wistar
2.
Curr Mol Pharmacol ; 3(1): 30-6, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-20030627

RESUMO

The Kv currents are divided into three different K+ currents, such as slow inactivating transient K+ current (I(D)), fast inactivating transient K+ current (I(A)) and dominant sustained K+ current (I(K)), in small-diameter rat trigeminal ganglion (TG) neurons. The concentration of alpha-DTX (an I(D) blocker) to evoke the maximal inhibition of I(A) was 0.1 microM, and this concentration caused a 20 % inhibition of I(A) and increased the number of action potentials. Irrespective of the presence of 0.1 microM alpha-DTX, the application of 0.5 mM 4-AP (an IA blocker) caused a 51 % inhibition of I(A) and increased the number of action potentials. The responses were associated with the decreases in the resting membrane potential (RMP) and duration of depolarization phase of action potential (DDP). The application of 2 mM tetraethylammonium (TEA, an I(K) blocker) produced a 55 % inhibition of I(K). Irrespective of the presence of both I(D) and I(A) blockers, the I(K) was the predominant K+ current. The prolongation of duration of action potential was usually observed following TEA treatment, suggesting that I(A) and I(K) had independent effects regulating the intrinsic firing properties of the action potential number and timing, respectively. Furthermore, the response characteristics of action potentials in the presence of both 4-AP and TEA resemble those of TG neurons in rats following chronic constriction nerve injury of the infraorbital nerve as well as after inferior alveolar nerve section. Thus, reducing effects of both I(A) and I(K) may be useful to investigate the mechanism of allodynia.


Assuntos
Neurônios/fisiologia , Gânglio Trigeminal/fisiologia , Potenciais de Ação/fisiologia , Animais , Fenômenos Eletrofisiológicos , Bloqueadores dos Canais de Potássio/farmacologia , Canais de Potássio de Abertura Dependente da Tensão da Membrana/metabolismo , Ratos , Transdução de Sinais
3.
Brain Res ; 1152: 64-74, 2007 Jun 04.
Artigo em Inglês | MEDLINE | ID: mdl-17433268

RESUMO

To determine whether there is a difference between a transient K(+) current (I(A)) and a sustained K(+) current (I(K)) regarding the neuronal function in small-diameter adult rat trigeminal ganglion (TG) neurons, which were insensitive to tetrodotoxin (TTX, 1 microM), we performed two different types of experiments. Primary cultures of dissociated TG neurons were prepared, and electrophysiological recordings were performed with the whole-cell configuration using the patch-clamp technique. In the voltage-clamp mode, two distinct K(+) current components, (I(A)) and (I(K)), were identified, and two different components (59.5% and 96.3%) of I(K) to the total K(+) current were observed at a +50 mV step-pulse. The IC(50) value for 4-aminoprydine (4-AP, 0.05-50 mM), which inhibited the I(A) by 50%, was 0.7 mM. That for tetraethylammonium (TEA, 0.02-20 mM) to inhibit 50% of I(K) was 1.5 mM. In the current-clamp mode, we used 0.5 mM 4-AP and 2 mM TEA at each concentration nearly equal to the IC(50) value. Irrespective of the absence or presence of TEA (2 mM), 0.5 mM 4-AP application increased the number of action potentials due to the decreased duration of the depolarization phase (DDP). TEA in the presence and absence of 4-AP prolonged the duration of action potentials as well as the duration of repolarization phase (DRP). These results suggested that I(A) and I(K) had independent effects regulating the intrinsic firing properties of the action potential number and timing, respectively, in adult rat TTX-R TG neurons.


Assuntos
Potenciais de Ação , Neurônios/fisiologia , Canais de Potássio/fisiologia , Tetrodotoxina/farmacologia , Gânglio Trigeminal/fisiologia , 4-Aminopiridina/farmacologia , Animais , Células Cultivadas , Técnicas de Patch-Clamp , Bloqueadores dos Canais de Potássio/farmacologia , Ratos , Ratos Wistar , Tetraetilamônio/farmacologia , Gânglio Trigeminal/citologia
4.
Neuropharmacology ; 52(3): 904-24, 2007 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17140607

RESUMO

We examined whether 8-bromo-cAMP (8-Br-cAMP)-induced modification of tetrodotoxin-resistant (TTX-R) sodium current in neonatal rat nodose ganglion neurons is mediated by the activation of protein kinase A (PKA) and/or protein kinase C (PKC). In 8-Br-cAMP applications ranging from 0.001 to 1.0mM, 8-Br-cAMP at 0.1mM showed a maximal increase in the peak TTX-R Na(+) (Nav1.8) current and produced a hyperpolarizing shift in the conductance-voltage (G-V) curve. The PKC inhibitor bisindolylmaleimide Ro-31-8425 (Ro-31-8425, 0.5microM) decreased the peak Nav 1.8 current. The Ro-31-8425-induced modulation of the G(V)(1/2) baseline (a percent change in G at baseline V1/2) was not affected by additional 8-Br-cAMP application (0.1mM). The maximal increase in Nav 1.8 currents was seen at 0.1microM after the application of a PKC activator, phorbol 12-myristate 13-acetate (PMA) and forskolin. The PMA-induced increase in Nav 1.8 currents was not significantly affected by additional 0.1mM 8-Br-cAMP application. Intracellular application of a PKA inhibitor, protein kinase inhibitor (PKI, 0.01mM), inhibited the baseline Nav 1.8 current, significantly attenuated the 8-Br-cAMP-and PMA-induced increase in the peak Nav 1.8 current, and caused a significant increase in the slope factor of the inactivation curve. The PKI application at a higher concentration (0.5mM) greatly inhibited the PMA (0.1microM)-induced increase in the peak Nav 1.8 current amplitude and further enhanced the Ro-31-8425-induced decrease in the current. These results suggest that the 8-Br-cAMP-induced increase in Nav 1.8 currents may be mediated by activation of both PKA and PKC.


Assuntos
8-Bromo Monofosfato de Adenosina Cíclica/farmacologia , Proteínas do Tecido Nervoso/fisiologia , Neurônios/efeitos dos fármacos , Gânglio Nodoso/citologia , Bloqueadores dos Canais de Sódio/farmacologia , Canais de Sódio/fisiologia , Tetrodotoxina/farmacologia , Animais , Animais Recém-Nascidos , Células Cultivadas , Colforsina/farmacologia , Relação Dose-Resposta a Droga , Interações Medicamentosas , Inibidores Enzimáticos/farmacologia , Expressão Gênica/fisiologia , Potenciais da Membrana/efeitos dos fármacos , Canal de Sódio Disparado por Voltagem NAV1.8 , Inibição Neural/efeitos dos fármacos , Inibição Neural/efeitos da radiação , Neurônios/citologia , Técnicas de Patch-Clamp , RNA Mensageiro/biossíntese , Ratos , Reação em Cadeia da Polimerase Via Transcriptase Reversa/métodos
5.
Brain Res ; 1107(1): 131-9, 2006 Aug 30.
Artigo em Inglês | MEDLINE | ID: mdl-16828719

RESUMO

In anesthetized, artificially ventilated rats with one vagus nerve section, the purposes of the present study were to investigate whether release from phasic consecutive hyperinflations (inflation volume=3 tidal volumes) results in the afterhyperpolarization (AHP) of the slowly adapting pulmonary stretch receptor (SAR) activity and whether the effect of ouabain, a Na+-K+ ATPase inhibitor, alters AHP of the SAR activity seen after release from maintained inflations. Release from 10 consecutive phasic hyperinflations did not cause any significant inhibition of SAR activity. Release from maintained inflations (for approximately 10 and 15 cmH2O) for 5 s produced the induction of disappearance of SAR activity, corresponding with the AHP. Intravenous administration of ouabain (20 and 40 microg/kg) had no significant effects on the responses of SAR activity and SAR adaptation index (AI) to maintained inflations, but ouabain treatment with at 40 microg/kg resulted in a significant increase in the SAR activity after stopping the respirator and significantly attenuated the AHP of the SAR activity. In the immunohistochemical study, we found Na+-K+ ATPase alpha3-subunit-isoforms-like immunoreactivity in SAR terminals, forming leaflike extensions in the intrapulmonary bronchioles at different diameters, and those terminals were buried in the smooth muscle. In the same sections, the alpha1 subunit immunoreactivity of SAR terminals was not found. These results suggest that the mechanism of generating the AHP of SARs is mainly mediated by the activation of Na+-K+ ATPase alpha3 subunit isoform.


Assuntos
Adaptação Fisiológica/efeitos dos fármacos , Inibidores Enzimáticos/farmacologia , Pulmão/efeitos dos fármacos , Ouabaína/farmacologia , Receptores Pulmonares de Alongamento/efeitos dos fármacos , Respiração Artificial , Potenciais de Ação/efeitos dos fármacos , Potenciais de Ação/fisiologia , Animais , Pressão Sanguínea/efeitos dos fármacos , Relação Dose-Resposta a Droga , Imuno-Histoquímica/métodos , Pulmão/fisiologia , Ratos , Ratos Wistar , ATPase Trocadora de Sódio-Potássio/metabolismo
6.
Life Sci ; 78(1): 112-20, 2005 Nov 19.
Artigo em Inglês | MEDLINE | ID: mdl-16115651

RESUMO

The combined effects of ouabain (Na(+)-K(+) ATPase inhibitor) and hyperinflation (inflation volume=three tidal volumes) on slowly adapting pulmonary stretch receptors (SARs) were studied before and after administration of nifedipine (an L-type Ca(2+) channel blocker) and KB-R7943 (a reverse-mode Na(+)-Ca(2+) exchanger blocker) in anesthetized, artificially ventilated rabbits after bilateral vagotomy. Before ouabain administration, hyperinflation stimulated SAR activity. After 20 min of ouabain administration (30 microg/kg) the SARs increased discharge rates in normal inflation. Under these conditions, hyperinflation initially stimulated SAR activity but subsequently inhibited the activity at peak inflation. Additional administration of 60 microg/kg ouabain (total dose=90 microg/kg) caused a further stimulation of SAR activity, but 20 min later both normal inflation and hyperinflation resulted in a greater inhibition of the receptor activity. The hyperinflation-induced SAR inhibition in the presence of ouabain (30 microg/kg) was not significantly altered by administration of either nifedipine (2 and 4 mg/kg) or KB-R7943 (1 and 3 mg/kg). In another series of experiments, we further examined the combined effects of ouabain and hyperinflation in veratridine (a Na(+) channel opener, 40 microg/kg)-treated animals. After recovery from the veratridine effect on SAR activity, which vigorously stimulated the receptor activity, ouabain treatment (30 microg/kg) that silenced the receptor activity at peak inflation greatly inhibited hyperinflation-induced SAR stimulation. These results suggest that hyperinflation-induced SAR inhibition in the presence of ouabain may be related to a Na(+) overload, but not to a Ca(2+) influx via activation of L-type Ca(2+) channels, in the SAR endings.


Assuntos
Inibidores Enzimáticos/farmacologia , Pulmão/fisiologia , Ouabaína/farmacologia , Receptores Pulmonares de Alongamento/efeitos dos fármacos , Animais , Bloqueadores dos Canais de Cálcio/farmacologia , Canais de Cálcio Tipo L/efeitos dos fármacos , Pulmão/efeitos dos fármacos , Terminações Nervosas/efeitos dos fármacos , Nifedipino/farmacologia , Coelhos , Respiração Artificial , Sódio/fisiologia , Tioureia/análogos & derivados , Tioureia/farmacologia , Vagotomia , Veratridina/farmacologia
7.
Life Sci ; 78(1): 47-53, 2005 Nov 19.
Artigo em Inglês | MEDLINE | ID: mdl-16111720

RESUMO

To determine how protein kinase C (PKC) activity influences properties of the tetrodotoxin-resistant sodium current (TTX-R I(Na)) in neonatal rat nodose ganglion (NG) neurons, we assessed the effects of phorbol,-12-myristate,13-acetate (PMA), one of the PKC activators, and staurosporine, one of the PKC inhibitors, on the current. PMA (30 and 100 nM) induced an increase in the peak current amplitude of normalized current-voltage curves, a leftward shift in the potential for half activation (V(1/2)) of normalized conductance-voltage curves and a leftward shift of V(1/2) potential for steady-state inactivation curves. The effects of staurosporine (0.1 and 1 muM) on the peak current amplitude and the V(1/2) potential for activation were opposite compared with those seen after PMA application. Staurosporine (1 muM) antagonized PMA (100 nM)-induced modification of TTX-R I(Na). These results suggest that the basal TTX-R I(Na) obtained from neonatal NG neurons is controlled by the level of PKC activity.


Assuntos
Neurônios/fisiologia , Gânglio Nodoso/metabolismo , Proteína Quinase C/fisiologia , Canais de Sódio/fisiologia , Animais , Animais Recém-Nascidos , Ativadores de Enzimas/farmacologia , Inibidores Enzimáticos/farmacologia , Cinética , Potenciais da Membrana/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Gânglio Nodoso/citologia , Gânglio Nodoso/efeitos dos fármacos , Técnicas de Patch-Clamp , Proteína Quinase C/antagonistas & inibidores , Ratos , Ratos Wistar , Estaurosporina/farmacologia , Acetato de Tetradecanoilforbol/farmacologia , Tetrodotoxina/farmacologia
8.
Br J Pharmacol ; 145(4): 503-13, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15821755

RESUMO

1 The aim of the present study was to investigate which EP receptor subtypes (EP1-EP4) act predominantly on the modification of the tetrodotoxin-resistant Na+ current (I(NaR)) in acutely isolated neonatal rat nodose ganglion (NG) neurones. 2 Of the four EP receptor agonists ranging from 0.01 to 10 muM, the EP2 receptor agonist (ONO-AE1-259, 0.1-10 microM) and the EP4 receptor agonist (ONO-AE1-329, 1 microM) significantly increased peak I(NaR). The responses were associated with a hyperpolarizing shift in the activation curve. 3 Neither the EP1 receptor agonist ONO-DI-004 nor the EP3 receptor agonist ONO-AE-248 significantly modified the properties of I(NaR). 4 In PGE2 applications ranging from 0.01 to 10 microM, 1 microM PGE2 produced a maximal increase in the peak I(NaR) amplitude. The PGE2 (1 microM)-induced increase in the GV(1/2) baseline (% change in G at baseline V(1/2)) was significantly attenuated by either intracellular application of the PKA inhibitor PKI or extracellular application of the protein kinase C inhibitor staurosporine (1 microM). However, the slope factor k was not significantly altered by PGE2 applications at 0.01-10 microM. In addition, the hyperpolarizing shift of V(1/2) by PGE2 was not significantly altered by either PKI or staurosporine. 5 In other series of experiments, reverse transcription-polymerase chain reaction (RT-PCR) of mRNA from nodose ganglia indicated that all four EP receptors were present. 6 The NG contained many neuronal cell bodies (diameter <30 microm) with intense or moderate EP2, EP3, and EP4 receptor-immunoreactivities. 7 These results suggest that the PGE2-induced modification of I(NaR) is mainly mediated by activation of both EP2 and EP4 receptors.


Assuntos
Dinoprostona/farmacologia , Neurônios/efeitos dos fármacos , Receptores de Prostaglandina E/fisiologia , Canais de Sódio/fisiologia , Tetrodotoxina/farmacologia , Alprostadil/análogos & derivados , Alprostadil/farmacologia , Animais , Animais Recém-Nascidos , Células Cultivadas , Proteínas Quinases Dependentes de AMP Cíclico/antagonistas & inibidores , Dinoprostona/análogos & derivados , Relação Dose-Resposta a Droga , Inibidores Enzimáticos/farmacologia , Fluoretos/farmacologia , Expressão Gênica/efeitos dos fármacos , Imuno-Histoquímica , Potenciais da Membrana/efeitos dos fármacos , Éteres Metílicos/farmacologia , Neurônios/metabolismo , Neurônios/fisiologia , Gânglio Nodoso/citologia , Gânglio Nodoso/efeitos dos fármacos , Gânglio Nodoso/fisiologia , Proteína Quinase C/antagonistas & inibidores , Proteína Quinase C/metabolismo , Inibidores de Proteínas Quinases/farmacologia , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Ratos , Ratos Wistar , Receptores de Prostaglandina E/agonistas , Receptores de Prostaglandina E/genética , Receptores de Prostaglandina E Subtipo EP1 , Receptores de Prostaglandina E Subtipo EP2 , Receptores de Prostaglandina E Subtipo EP3 , Receptores de Prostaglandina E Subtipo EP4 , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Estaurosporina/farmacologia , Fatores de Tempo
9.
J Pharmacol Exp Ther ; 314(1): 437-45, 2005 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15831438

RESUMO

To determine whether the alpha-dendrotoxin (alpha-DTX)-sensitive current [D current, slow inactivating transient current (I(D))] contributes to the modification of neuronal function in small-diameter adult rat trigeminal ganglion (TG) neurons insensitive to 1 microM tetrodotoxin (TTX), we performed two different types of experiments. In the voltage-clamp mode, two distinct K+ current components, a fast inactivating transient current (I(A)) and a dominant sustained current (I(K)), were identified. Alpha-DTX (0.1 microM), ranging from 0.001 to 1 microM, maximally decreased I(A) by approximately 20% and I(K) by approximately 16.1% at a +50-mV step pulse, and 0.1 microM alpha-DTX application increased the number of action potentials without changing the resting membrane potential. Irrespective of the absence and presence of 0.1 microM alpha-DTX, applications of 4-aminopyridine (4-AP; 0.5 mM) and tetraethylammonium (TEA; 2 mM) inhibited approximately 50% inhibition of I(A) and I(K), respectively. 4-AP (0.5 mM) depolarized the resting membrane potential and increased the number of action potentials in the absence or presence of 0.1 microM alpha-DTX. TEA prolonged the duration of action potentials in the absence or presence of 0.1 microM alpha-DTX. These results suggest that I(D) contributes to the modification of neuronal function in adult rat TTX-resistant TG neurons, but after the loss of I(D) due to 0.1 microM alpha-DTX application, 4-AP (0.5 mM) and TEA (2 mM) still regulate the intrinsic firing properties of action potential number and shape.


Assuntos
Potenciais de Ação/efeitos dos fármacos , Venenos Elapídicos/farmacologia , Neurônios/efeitos dos fármacos , Canais de Potássio/efeitos dos fármacos , Tetrodotoxina/farmacologia , Gânglio Trigeminal/citologia , Animais , Células Cultivadas , Resistência a Medicamentos , Eletrofisiologia , Técnicas de Patch-Clamp , Bloqueadores dos Canais de Potássio/farmacologia , Ratos , Ratos Wistar , Tetraetilamônio/farmacologia , Gânglio Trigeminal/efeitos dos fármacos
10.
Chem Senses ; 29(4): 351-61, 2004 May.
Artigo em Inglês | MEDLINE | ID: mdl-15150148

RESUMO

Inhibitory responses of slowly adapting pulmonary stretch receptor (SAR) activity to CO(2) inhalation (maximal tracheal CO(2) concentration ranging from 9.5 to 12.5%) for approximately 60 s were examined before and after administration of acetazolamide (a carbonic anhydrase inhibitor) or 4-aminopyridine (4-AP, a K(+) channel blocker). The experiments were performed in 35 anesthetized, artificially ventilated rats after unilateral vagotomy. Sixty-eight of eighty-four SARs were inhibited by CO(2) inhalation. The SAR inhibition was attenuated by pretreatment with either acetazolamide (20 mg/kg, n = 10) or 4-AP (0.7 and 2.0 mg/kg, n = 10). In other series of experiments, stainings to show the existence of carbonic anhydrase (CA) enzymatic reaction were not found in the smooth muscle of either extrapulmonary or intrapulmonary bronchi. Protein gene product 9.5 (PGP 9.5)-immunoreactive SAR terminals to form leaflike extensions were found in the bronchioles at different diameters and were smooth-muscle-related receptors. But in the same sections, CA isozyme II-like (erythrocyte CA) immunoreactive SAR terminals were not identified. These results suggest that CO(2)-induced inhibition of SARs may be involved in the CA-dependent CO(2) hydration in addition to the activation of 4-AP sensitive K(+) currents.


Assuntos
4-Aminopiridina/farmacologia , Acetazolamida/farmacologia , Dióxido de Carbono/antagonistas & inibidores , Inibidores da Anidrase Carbônica/farmacologia , Bloqueadores dos Canais de Potássio/farmacologia , Receptores Pulmonares de Alongamento/fisiologia , Administração por Inalação , Animais , Dióxido de Carbono/administração & dosagem , Anidrase Carbônica II/fisiologia , Miócitos de Músculo Liso/citologia , Ratos , Traqueia/citologia
11.
Brain Res Bull ; 58(1): 83-9, 2002 May.
Artigo em Inglês | MEDLINE | ID: mdl-12121817

RESUMO

The aim of the present study is to clarify whether physiological stimulation of vagal afferents modulates the activity of the trigeminal spinal nucleus oralis (TSNO) neurons related to the tooth-pulp (TP)-evoked jaw-opening reflex (JOR) in pentobarbital-anesthetized rats. The activity of TSNO neurons and the amplitude of digastric electromyogram (dEMG) increased proportionally during 1.0-3.5 times the threshold for JOR. The amplitude of the dEMG of 14 out of 17 rats was suppressed by physiological stimulation of vagal afferents after intravenous infusion of Ficoll. Out of 23, 18 TSNO unit activities in 14 rats were also suppressed by Ficoll infusion. This suppressive effect of unit and dEMG activities returned to the control level within 25 min. After administration of naloxone (0.5 and 1.0 mg/kg, i.v.) the suppressive effect of Ficoll infusion on the activity of TSNO neurons (5/7) was significantly attenuated compared to the control (p < 0.01). The inhibition TSNO neuronal and dEMG activities by Ficoll infusion was volume-dependent in a range of 5-10% of total blood volume. Furthermore, right vagus nerve ligation greatly inhibited the suppressive effect of Ficoll-induced TSNO activity. These results therefore suggest that low-pressure cardiopulmonary baroreceptors whose afferents travel in the vagus nerve inhibit the pulpal nociceptive transmission.


Assuntos
Polpa Dentária/inervação , Arcada Osseodentária/fisiologia , Reflexo/fisiologia , Núcleo Espinal do Trigêmeo/fisiologia , Nervo Vago/fisiologia , Animais , Estimulação Elétrica , Eletromiografia , Dor Facial/fisiopatologia , Ficoll/farmacologia , Ligadura , Masculino , Naloxona/farmacologia , Antagonistas de Entorpecentes/farmacologia , Neurônios Aferentes/efeitos dos fármacos , Neurônios Aferentes/fisiologia , Nociceptores/efeitos dos fármacos , Nociceptores/fisiologia , Ratos , Núcleo Espinal do Trigêmeo/citologia , Nervo Vago/citologia
12.
J Pharmacol Exp Ther ; 300(2): 597-604, 2002 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11805222

RESUMO

The excitatory responses of deflationary slowly adapting pulmonary stretch receptor (SAR) activity to lung deflation ranging from approximately -15 to -25 cm of H(2)O for approximately 5 s were examined before and after administration of flecainide, a Na(+) channel blocker, and K(+) channel blockers, such as 4-aminopyridine (4-AP) and tetraethylammonium (TEA). The experiments were performed in anesthetized, artificially ventilated rats after unilateral vagotomy. The deflationary SARs increased their activity during lung deflation and its effect became more pronounced by increasing the degree of negative pressure. During lung deflation the average values for the deflationary SAR adaptation index (AI) were below 40%. Intravenous administration of veratridine (50 microg/kg), an Na(+) channel opener, stimulated deflationary SAR activity: one maintained excitatory activity mainly during deflation and the other receptors showed a tonic discharge during both deflation and inflation. Despite the difference in deflationary SAR firing patterns after veratridine administration, flecainide treatment (6.0 mg/kg) blocked veratridine-induced deflationary SAR stimulation and also caused strong inhibition of the excitatory responses of deflationary SARs to lung deflation. Under these conditions, the average values for deflationary SAR AI were over 90%. The responses of deflationary SARs and deflationary SAR AI to lung deflation were not significantly altered by pretreatment with either 4-AP (0.7 and 2.0 mg/kg) or TEA (2.0 and 6.0 mg/kg). These results suggest that the excitatory effect of lung deflation on deflationary SAR activity is mediated by the activation of flecainide-sensitive Na(+) channels on the nerve terminals of deflationary SARs.


Assuntos
Pulmão/fisiologia , Receptores Pulmonares de Alongamento/fisiologia , 4-Aminopiridina/farmacologia , Anestesia , Animais , Antiarrítmicos/administração & dosagem , Antiarrítmicos/farmacologia , Flecainida/administração & dosagem , Flecainida/farmacologia , Injeções Intravenosas , Pulmão/efeitos dos fármacos , Bainha de Mielina/fisiologia , Fibras Nervosas Mielinizadas/fisiologia , Bloqueadores dos Canais de Potássio , Canais de Potássio/fisiologia , Receptores Pulmonares de Alongamento/efeitos dos fármacos , Ratos , Ratos Wistar , Respiração Artificial , Nervo Isquiático/fisiologia , Tetraetilamônio/farmacologia , Vagotomia , Veratridina/administração & dosagem , Veratridina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...